Chemcrux Enterprises Limited (BOM:540395)

Market Cap	1.30B -35.0%
Revenue (ttm)	806.46M +14.1%
Net Income	37.31M -4.7%
EPS	2.52 -4.5%
Shares Out	14.81M
PE Ratio	34.89
Forward PE	n/a
Dividend	1.00 (1.14%)
Ex-Dividend Date	Sep 17, 2025

Volume	3,656
Open	88.25
Previous Close	88.26
Day's Range	86.75 - 89.49
52-Week Range	64.00 - 158.60
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 3, 2026

About Chemcrux Enterprises

Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic acid, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoy...

• Industry: Chemicals and Allied Products
• Founded: 1983
• Employees: 102
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540395

Financial Performance

In fiscal year 2026, Chemcrux Enterprises's revenue was 806.46 million, an increase of 14.12% compared to the previous year's 706.67 million. Earnings were 37.31 million, a decrease of -4.66%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 8, 2026

Data Sources Report a data error